Exact Mass: 410.9782
Exact Mass Matches: 410.9782
Found 35 metabolites which its exact mass value is equals to given mass value 410.9782,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Iomazenil
ethyl 11-iodo-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0²,⁶]tetradeca-1(14),3,5,10,12-pentaene-5-carboxylate
Pyridinium-3,5-bisthiocarboxylate mononucleotide; P2TMN; Pyridin-1-ium-3,5-bisthiocarboxylate mononucleotide
Pyridinium-3,5-bisthiocarboxylate mononucleotide; P2TMN; Pyridin-1-ium-3,5-bisthiocarboxylate mononucleotide
Methyl 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
Methyl 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
disodium 5-[(4-nitro-2-sulphonatophenyl)azo]salicylate
disodium 5-[(4-nitro-2-sulphonatophenyl)azo]salicylate
2-Amino-6-(2-(sulfooxy)ethylsulfonyl)naphthalene-1-sulfonic acid
2-Amino-6-(2-(sulfooxy)ethylsulfonyl)naphthalene-1-sulfonic acid
sodium 5-hydroxy-6-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-1-sulphonate
sodium 5-hydroxy-6-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-1-sulphonate
6-Bromo-1-carbethoxy-4-methyl-2, 7-dibenz[f,ij]isoquinoline-2,7-dione
6-Bromo-1-carbethoxy-4-methyl-2, 7-dibenz[f,ij]isoquinoline-2,7-dione
ethylenediaminetetraacetic acid disodium cobalt salt, hydrate
ethylenediaminetetraacetic acid disodium cobalt salt, hydrate
[(E)-[3-bromo-4-[(2-fluorophenyl)methoxy]-5-methoxyphenyl]methylideneamino]thiourea
[(E)-[3-bromo-4-[(2-fluorophenyl)methoxy]-5-methoxyphenyl]methylideneamino]thiourea
(1R,3R)-N-[1-(4-bromophenyl)ethyl]-2,2-dichloro-3-methyl-1-[(S)-methylsulfinyl]cyclopropane-1-carboxamide
(1R,3R)-N-[1-(4-bromophenyl)ethyl]-2,2-dichloro-3-methyl-1-[(S)-methylsulfinyl]cyclopropane-1-carboxamide
2-(3-bromophenyl)-N-(4,5-dihydro-1,3-thiazol-2-yl)quinoline-4-carboxamide
2-(3-bromophenyl)-N-(4,5-dihydro-1,3-thiazol-2-yl)quinoline-4-carboxamide
2-[[4-(4-Bromophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid
2-[[4-(4-Bromophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid
4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide
4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide
(4-Chlorophenyl)-[6,7-dichloro-4-[(dimethylamino)methyl]-5-hydroxy-2-methyl-3-benzofuranyl]methanone
(4-Chlorophenyl)-[6,7-dichloro-4-[(dimethylamino)methyl]-5-hydroxy-2-methyl-3-benzofuranyl]methanone
2,5-dichloro-N-methyl-N-[[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]benzenesulfonamide
2,5-dichloro-N-methyl-N-[[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]benzenesulfonamide
2-(4-Bromophenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester
2-(4-Bromophenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester
N-[5-[(2,6-dichlorophenyl)methylthio]-1,3,4-thiadiazol-2-yl]-5-methyl-2-pyrazinecarboxamide
N-[5-[(2,6-dichlorophenyl)methylthio]-1,3,4-thiadiazol-2-yl]-5-methyl-2-pyrazinecarboxamide
BX430
BX430
BX430 is a potent and selective noncompetitive allosteric human P2X4 receptor channels antagonist with an IC50 of 0.54 μM. BX430 has species specificity. BX430 is used for chronic pain and cardiovascular disease.
(3s,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(21),2(12),4,7,14,16,18-heptaene-6,13-dione
(3s,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(21),2(12),4,7,14,16,18-heptaene-6,13-dione
2-(3,5-dibromo-4-butoxy-1-hydroxy-4-methoxycyclohexa-2,5-dien-1-yl)ethanimidic acid
2-(3,5-dibromo-4-butoxy-1-hydroxy-4-methoxycyclohexa-2,5-dien-1-yl)ethanimidic acid
2-(4-{1,6-dichloro-3h-pyrrolo[2,3-c]quinolin-4-yl}-1,3-thiazol-2-yl)phenol
2-(4-{1,6-dichloro-3h-pyrrolo[2,3-c]quinolin-4-yl}-1,3-thiazol-2-yl)phenol
